Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals.
Suspitsin EN, Grigoriev MY, Togo AV, Kuligina ES, Belogubova EV, Pozharisski KM, Chagunava OL, Sokolov EP, Theillet C, Berstein LM, Hanson KP, Imyanitov EN. Suspitsin EN, et al. Among authors: theillet c. Eur J Cancer. 2002 Sep;38(14):1911-6. doi: 10.1016/s0959-8049(02)00149-1. Eur J Cancer. 2002. PMID: 12204674
Evidence for microsatellite instability in bilateral breast carcinomas.
Imyanitov EN, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisski KM, Turkevich EA, Hanson KP, Hayward NK, Chenevix-Trench G, Theillet C, Lavin MF. Imyanitov EN, et al. Among authors: theillet c. Cancer Lett. 2000 Jun 1;154(1):9-17. doi: 10.1016/s0304-3835(99)00444-9. Cancer Lett. 2000. PMID: 10799734
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.
Kuligina ES, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisskiy KM, Chagunava OL, Berstein LM, Theillet C, Hanson KP, Imyanitov EN. Kuligina ES, et al. Among authors: theillet c. Cancer Lett. 2000 Aug 1;156(1):45-50. doi: 10.1016/s0304-3835(00)00436-5. Cancer Lett. 2000. PMID: 10840158
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al. Phelan CM, et al. Among authors: theillet c. Cancer Res. 1998 Mar 1;58(5):1004-12. Cancer Res. 1998. PMID: 9500463
p53 mutations occur in aggressive breast cancer.
Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C. Mazars R, et al. Among authors: theillet c. Cancer Res. 1992 Jul 15;52(14):3918-23. Cancer Res. 1992. PMID: 1617667
144 results